Dr. Katharina Lobisch SRL
Dr. Katharina Lobisch reported total assets of 135,083 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Dr. Katharina Lobisch shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +4364 % Total assets +3644 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Katharina Lobisch's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Sep 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
Dr. Katharina Lobisch's financial analysis
- Solvency74.6%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Katharina Lobisch
Dr. Katharina Lobisch's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.507.371
- VAT number
- BE1002507371
- Peppol
- Registered · 0208:1002507371 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2023
- Registered office
- 3070 Kortenberg
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Katharina Lobisch (SRL) has been based in Kortenberg since 2023, active in: general medical practice activities. For 2025, it reports a net profit of 41,722 € and equity of 100,788 €; its revenue is not published. Its solvency stands at 74.6%, above the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Katharina Lobisch
Companies in the same business, of comparable size and area, outside its group.
- Docteur Manuel Riolo General medical practice activities Woluwe-Saint-Lambert · balance sheet 143,380 €
- Toon Van Hoof General medical practice activities Boortmeerbeek · balance sheet 120,363 €
- Catry-Vancaster General medical practice activities Chaumont-Gistoux · balance sheet 115,450 €
- Dokter Marie Groffi General medical practice activities Mechelen · balance sheet 102,941 €
- Cabinet médical du Docteur Ividiu SUCIU General medical practice activities Sankt Vith · balance sheet 129,810 €
- Michel Duchateau SRL General medical practice activities Saint-Nicolas · balance sheet 163,999 €
- Centre médical Stéphanie General medical practice activities Ixelles · balance sheet 135,199 €
- Huisarts – Sportarts Jasper D’Eer General medical practice activities Sint-Niklaas · balance sheet 134,865 €
Frequently asked questions about Dr. Katharina Lobisch
What is the revenue of Dr. Katharina Lobisch?
Dr. Katharina Lobisch files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Katharina Lobisch?
In Belgium, the VAT number is the company number prefixed with BE: BE1002507371 for Dr. Katharina Lobisch, if the company is VAT-registered. Its company number (CBE) is 1002.507.371.
Where is the registered office of Dr. Katharina Lobisch?
According to the CBE register, the registered office of Dr. Katharina Lobisch is in 3070 Kortenberg.
What is the equity of Dr. Katharina Lobisch?
At the close of the 2025 financial year, the equity of Dr. Katharina Lobisch amounts to 100,788 €, a solvency of 74.6% of total assets.
Who manages Dr. Katharina Lobisch?
The register lists 1 active mandates at Dr. Katharina Lobisch. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Katharina Lobisch
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →